James P Farmer

Summary

Publications

  1. ncbi Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis
    James P Farmer
    Department of Pathology and Laboratory Medicine, Ottawa Hospital and University of Ottawa, Ont
    Can J Ophthalmol 40:151-60. 2005
  2. ncbi Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis
    James P Farmer
    University of Ottawa Eye Institute, Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ontario, Canada
    Can J Ophthalmol 41:216-20. 2006
  3. ncbi Characterization of lymphoproliferative lesions of the conjunctiva: immunohistochemical and molecular genetic studies
    James P Farmer
    Department of Pathology, University of Ottawa, ON, Canada
    Can J Ophthalmol 41:753-60. 2006

Detail Information

Publications3

  1. ncbi Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis
    James P Farmer
    Department of Pathology and Laboratory Medicine, Ottawa Hospital and University of Ottawa, Ont
    Can J Ophthalmol 40:151-60. 2005
    ..Primary tumours, a hIgH proportion of which have MALT characteristics, have a favourable prognosis. Molecular genetic studies may be useful when morphologic and immunophenotypic studies give equivocal results...
  2. ncbi Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis
    James P Farmer
    University of Ottawa Eye Institute, Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ontario, Canada
    Can J Ophthalmol 41:216-20. 2006
    ..It is important to consider it preoperatively because the vascular nature of this tumour may create problems with hemostasis during excision...
  3. ncbi Characterization of lymphoproliferative lesions of the conjunctiva: immunohistochemical and molecular genetic studies
    James P Farmer
    Department of Pathology, University of Ottawa, ON, Canada
    Can J Ophthalmol 41:753-60. 2006
    ..Conjunctival lymphoproliferative lesions have not been selected for independent analysis with newer immunohistochemical and molecular genetic techniques to highlight their unique profile...